To study the clinical efficacy of Bushen Yifei Recipe combined with Salmeterol Fluticasone in the treatment of COPD patients with pulmonary infection.Methods:A total of 138 COPD patients with pulmonary infection admitted to our hospital from July 2014 to July 2018 were included in this study.They were divided into an observation group(n=69)and a control group(n=69)according to the random number table method.The control group was given conventional treatment and Salmeterol Fluticasone.The observation group was treated with conventional treatment, Salmeterol Fluticasone and Bushen Yifei Recipe.Before and after treatment, blood gas analysis indexes such as SaO2(Arterial oxygen saturation), PaO2(Arterial oxygen partial pressure), PaCO2(Arterial carbon dioxide partial pressure), pulmonary function indexes such as FVC(Forced vital capacity), FEV1, inflammatory factors such as serum IL-6(Interleukin-6), TNF-α(Tumor necrosis factor-α), CRP(C-reactive protein), Plasma MSP(Macrophage stimulating protein), Serum amyloid A(SAA), Haptoglobin(HPT), and adverse reactions were observed.Results:After treatment, SaO2, PaO2, FEV1 and FVC in the observation group were higher than those in the control group, while PaCO2, IL-6, TNF-α, CRP, MSP, SAA and HPT were lower than those in the control group(P<0.05).The total effective rate of the observation group(84.06%)was higher than that of the control group(63.77 %)(P<0.05).During the treatment period, no significant adverse events occurred in both groups.Conclusion:Bushen Yifei Recipe combined with Salmeterol and Fluticasone in the treatment of MOCD patients with lung infection can invigorate the kidney and benefit the lung, eliminate phlegm and asthma, remove inflammatory factors, improve blood gas analysis, lung function, inflammatory factors and MSP, SAA, HPT and other indicators, with obvious curative effect, safety and reliability. |